Evidence map›Paper›PMID 37267168›Full record

ArticleJournal of addiction medicine

Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration.

Madeline C Frost, Eric J Hawkins, Joseph E Glass, Kevin A Hallgren, Emily C Williams

Open access · greenAbstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Madeline C FrostFrom the Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle, WA (MCF, JEG, KAH, ECW); Health Services Research & Development (HSR&D) Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, WA (MCF, EJH, ECW); Center of Excellence in Substance Addiction Treatment and Education, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, WA (EJH); Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA (EJH, JEG, KAH); Kaiser Permanente Washington Health Research Institute, Seattle, WA (JEG, KAH).
Eric J Hawkins
Joseph E Glass
Kevin A Hallgren
Emily C Williams
Center for Excellence in Education · USKing Abdul Aziz University Hospital · SANational Institute on Alcohol Abuse and Alcoholism · US

Funding

Patterns of Alcohol Use and Alcohol-Related Care Among Transgender PersonsR21AA025973 · NIAAA · UNIVERSITY OF WASHINGTON · PI BLOSNICH, JOHN RUDOLPH, WILLIAMS, EMILY CATERINA · 2018 to 2019
$438k
NIAAA NIH HHS R21 AA025973
6 · The paper itself

Abstract

objectivesAmong people with opioid use disorder (OUD), having a co-occurring substance use disorder (SUD) is associated with lower likelihood of receiving OUD treatment medications (MOUD). However, it is unclear how distinct co-occurring SUDs are associated with MOUD receipt. This study examined associations of distinct co-occurring SUDs with initiation and continuation of MOUD among patients with OUD in the national Veterans Health Administration (VA).

methodsElectronic health record data were extracted for outpatients with OUD who received care August 1, 2016, to July 31, 2017. Analyses were conducted separately among patients without and with prior-year MOUD receipt to examine initiation and continuation, respectively. SUDs were measured using diagnostic codes; MOUD receipt was measured using prescription fills/clinic visits. Adjusted regression models estimated likelihood of following-year MOUD receipt for patients with each co-occurring SUD relative to those without.

resultsAmong 23,990 patients without prior-year MOUD receipt, 12% initiated in the following year. Alcohol use disorder (adjusted incidence rate ratio [aIRR], 0.80; 95% confidence interval [CI], 0.72-0.90) and cannabis use disorder (aIRR, 0.78; 95% CI, 0.70-0.87) were negatively associated with initiation. Among 11,854 patients with prior-year MOUD receipt, 83% continued in the following year. Alcohol use disorder (aIRR, 0.94; 95% CI, 0.91-0.97), amphetamine/other stimulant use disorder (aIRR, 0.94; 95% CI, 0.90-0.99), and cannabis use disorder (aIRR, 0.95; 95% CI, 0.93-0.98) were negatively associated with continuation.

conclusionsIn this study of national VA outpatients with OUD, those with certain co-occurring SUDs were less likely to initiate or continue MOUD. Further research is needed to identify barriers related to specific co-occurring SUDs.

Indexed as

AlcoholismBuprenorphineMarijuana AbuseOpioid-Related DisordersAnalgesics, OpioidHumansOpiate Substitution TreatmentOutpatientsVeterans HealthAnalgesics, OpioidBuprenorphine

Identifiers

PMID37267168
PMCPMC10110763
OpenAlexW4306699174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.